The layoffs cut into The Post’s local, international and sports coverage, and reduced its entire work force by about 30 percent. The layoffs cut into The Post’s local, international and sports ...
Common-sense journalism has officially hit the Golden State — and can soon hit your doorstep with home delivery of the California Post. The brand-new, seven-days-a-week print edition features the ...
The family-owned company that operates the newspaper cited mounting losses and labor constraints. A final edition is expected on Sunday, May 3. By Mark Walker and Emmett Lindner The family-owned ...
Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced positive ...
The California Post is set to launch early next year, bringing the nation's most popular tabloid to the Golden State. The New York Post is going Hollywood. The nation’s most popular tabloid will ...
If someone sends a message with an uploaded file whose filename contains non-ASCII characters, we end up percent-encoding those characters in the URL in the message's link to the file. The resulting ...
Flutter and DraftKings dominate the US sports betting and iGaming markets, holding a combined 66.1% market share and benefiting from economies of scale. The US sports betting market is still far from ...
Department of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, United States Omenn-Darling Bioengineering Institute, Princeton University, Princeton, New Jersey ...
Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program. The asset in question, dubbed ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today ...